FDA Approves Valve Replacement System for Tricuspid Regurgitation
The approval marks the first transcatheter replacement device indicated for use in the tricuspid position.
Read More
Month: February 2024
FDA Grants Second Approval for Pulsed Field Ablation to Boston Scientific
The system is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation and is a new alternative to standard-of-care thermal ablation treatment.
Read More